Long noncoding RNA CRNDE as a potential biomarker for the development and prognosis of cervical cancer

Objective: The long noncoding RNA CRNDE has been reported to be a good biomarker for poor prognosis in a variety of human cancers. However, whether CRNDE could serve as novel biomarker to predict prognosis in cervical cancer or not is unknown. The aim of the present study was to examine the expression of CRNDE in cervical cancers and to investigate the relationship between this lncRNA expression and cervical squamous cell cancer susceptibility and prognosis. Materials and Methods: The expression of CRNDE in 192 cervical cancer tissues and matched 192 adjacent normal tissues were detected by quantitative real-time RT-PCR and its correlation with the clinical characteristic and prognosis were analyzed. Results: The results showed that CRNDE was upregulated in 192 cervical cancer tissues compared with those in the adjacent normal tissues (p < 0.001). Furthermore, CRNDE expression was positively correlated with FIGO stage (p < 0.0001), lymph node metastasis (p < 0.0001), depth of cervical invasion (p < 0.0001), and tumor size (p = 0.006), but not other clinical characteristics. Moreover, Kaplan–Meier analysis demonstrated that decreased CRNDE expression contributed to poor overall survival (p < 0.001) and disease-free survival (p < 0.001) of patients. A multivariate survival analysis also indicated that CRNDE could be an independent prognostic marker. Furthermore, knockdown of CRNDE expression by small interfering RNA (siRNA) could inhibite cell proliferation and prompted cell apoptosis. Conclusions: The present data indicate that high expression of CRNDE is involved in cervical cancer progression and could be a potential target for diagnosis and gene therapy.

Long noncoding RNA CRNDE; Biomarker; Cervical cancer.

[1] Guo Q., Dong B., Nan F., Guan D., Zhang Y.: “5-Aminolevulinic Acid Photodynamic Therapy in Human Cervical Cancer Via the Activation of Microrna-143 and Suppression of the Bcl-2/Bax Signaling Pathway”. Mol. Med. Rep., 2016, 14, 544.

[2] Tortora M., Annunziata C., Liguori G., Losito S., Botti G., Greggi S., et al.: “Detection of human papillomavirus DNA in peri-tumor tissues and pelvic lymph nodes as potential molecular marker of micrometastasis in cervical cancer”. Infect. Agent. Cancer., 2016, 11, 22.

[3] Nowakowski A., A. Ś., Seroczyński P., Cybulski M., Teter Z.: “Reimbursed Costs of Management of Uterine Cervical Neoplasia in Poland - a Descriptive Analysis Based on the Data from the National Health Fund”. Cent. Eur. J. Public. Health., 2016, 24.

[4] Oga E.A., Brown J.P., Brown C., Dareng E., Adekanmbi V., Odutola M., et al.: “Recurrence of cervical intraepithelial lesions after thermo-coagulation in HIV-positive and HIV-negative Nigerian women”. BMC. Womens Health., 2016, 16, 25.

[5] Goedert L., Pereira C.G., Roszik J., Placa J.R., Cardoso C., Chen G., et al.: “RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma”. Oncotarget., 2016, 7, 36711.

[6] Lan W.G., Xu D.H., Xu C., Ding C.L., Ning F.L., Zhou Y.L., et al.: “Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells”. Oncol. Rep., 2016, 36, 263.

[7] Yan Y., Han J., Li Z., Yang H., Sui Y., Wang M.: “Elevated RNA expression of long noncoding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma”. Mol. Med. Rep., 2016, 13, 5125.

[8] Haemmerle M., Gutschner T.: “Long non-coding RNAs in cancer and development: where do we go from here?”. Int. J. Mol. Sci., 2015, 16, 1395.

[9] Qiu M.T., Hu J.W., Yin R., Xu L.: “Long noncoding RNA: an emerging paradigm of cancer research”. Tumour. Biol., 2013, 34, 613.

[10] Gloss B.S., Dinger M.E.: “The specificity of long noncoding RNA expression. Biochimica et biophysica acta”. Biochim. Biophys. Acta., 2016, 1859, 16.

[11] Isin M., Dalay N.: “LncRNAs and neoplasia”. Clin. Chim. Acta., 2015, 444, 280.

[12] Atri M., Zhang Z., Dehdashti F., Lee S.I., Ali S., Marques H., et al.: “Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial”. Gynecol. Oncol., 2016, 142, 413.

[13] Eminowicz G., Motlib J., Khan S., Perna C., McCormack M.: “Pelvic Organ Motion during Radiotherapy for Cervical Cancer: Understanding Patterns and Recommended Patient Preparation”. Clin. Oncol. (R Coll Radiol), 2016, 28, e85.

[14] Smeltzer S., Yu X., Schmeler K.M., Peters Y., Levison J.: “Abnormal Vaginal Pap Smear After Hysterectomy in HIV Infected Women Without History of Cervical Dysplasia or Cancer”. Obstet. Gynecol., 2016, 127, 4s.

[15] Zhang M., Wang W., Li T., Yu X., Zhu Y., Ding F., et al.: “Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis”. Biomed. Pharmacother., 2016, 80, 73.

[16] Zhang Y., He Q., Hu Z., Feng Y., Fan L., Tang Z., et al.: “Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer”. Nat. Struct. Mol. Biol., 2016, 23, 522.

[17] Cao S., Liu W., Li F., Zhao W., Qin C.: “Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer”. Int. J. Clin. Exp. Pathol., 2013, 7, 6776.

[18] Liao L.M., Sun X.Y., Liu A.W., Wu J.B., Cheng X.L., Lin J.X., et al.: “Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c- Myc in cervical cancer”. Gynecol. Oncol., 2014, 133, 616.

[19] Jiang S., Wang HL., Yang J.: “Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer”. Int. J. Clin. Exp. Pathol., 2015, 8, 806.

[20] Yang M., Zhai X., Xia B., Wang Y., Lou G.: “Long noncoding RNA CCHE1 promotes cervical cancer cell proliferation via upregulating PCNA”. Tumour. Biol., 2015, 36, 7615.

[21] Kim H.J., Lee D.W., Yim G.W., Nam E.J., Kim S., Sang W.K., et al.: “Long non-coding RNA HOTAIR is associated with human cervical cancer progression”. Int. J. Oncol., 2015, 46, 521.

[22] Zhang Y., Wang T., Huang H.Q., Li W., Cheng X.L., Yang J.: “Human MALAT-1 long non-coding RNA is overexpressed in cervical cancer metastasis and promotes cell proliferation, invasion and migration”. J. buon., 2015, 20, 1497.

[23] Zhang J., Yao T., Wang Y., Yu J., Liu Y., Lin Z.: “Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21”. Cancer. Biol. Ther., 2015, 17, 104.